Cargando…

Clinical characteristics of patients diagnosed with COVID-19 in Beijing

This study aimed to determine the clinical characteristics of patients diagnosed with the coronavirus disease 2019 (COVID-19). Clinical data of COVID-19 patients diagnosed between January 28, 2020 and February 23, 2020 at the Beijing You'an Hospital were summarized and analyzed. Overall, 45 (18...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Aihua, Yan, Benyong, Hua, Wei, Feng, Dandan, Xu, Bin, Liang, Lianchun, Guo, Caiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Medical Association Publishing House. Published by Elsevier B.V. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217107/
https://www.ncbi.nlm.nih.gov/pubmed/32835210
http://dx.doi.org/10.1016/j.bsheal.2020.05.003
_version_ 1783532549764546560
author Jin, Aihua
Yan, Benyong
Hua, Wei
Feng, Dandan
Xu, Bin
Liang, Lianchun
Guo, Caiping
author_facet Jin, Aihua
Yan, Benyong
Hua, Wei
Feng, Dandan
Xu, Bin
Liang, Lianchun
Guo, Caiping
author_sort Jin, Aihua
collection PubMed
description This study aimed to determine the clinical characteristics of patients diagnosed with the coronavirus disease 2019 (COVID-19). Clinical data of COVID-19 patients diagnosed between January 28, 2020 and February 23, 2020 at the Beijing You'an Hospital were summarized and analyzed. Overall, 45 (18 men and 27 women) patients were included in this study. The average age of patients was 58 years (range, 7–94 years). Furthermore, 21 patients (47%) experienced underlying chronic diseases, with another four patients (9%) having three or more chronic diseases simultaneously. The first symptoms appeared at the onset of illness onset include fever in 36 patients (80%), cough in 23 patients (51%), and expectoration in 15 patients (33%), respectively. Patients may experience hepatic and renal injury as well as abnormal myocardial enzymes in varying degrees. Senior patients (≥58) and accompanying chronic diseases were considered as independent predictors for developing a severe and critically ill population with increased mortality. Laboratory results regarding the NEU percentage, NLR, ALC, and C-reactive protein levels were considered significant in predicting clinically critical disease or for prognosis assessment and thus require further studies. COVID-19 may affect multiple organs of the human body. Glucocorticoid is considered effective in the treatment of patients diagnosed with severe COVID-19.
format Online
Article
Text
id pubmed-7217107
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Chinese Medical Association Publishing House. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-72171072020-05-12 Clinical characteristics of patients diagnosed with COVID-19 in Beijing Jin, Aihua Yan, Benyong Hua, Wei Feng, Dandan Xu, Bin Liang, Lianchun Guo, Caiping Biosaf Health Article This study aimed to determine the clinical characteristics of patients diagnosed with the coronavirus disease 2019 (COVID-19). Clinical data of COVID-19 patients diagnosed between January 28, 2020 and February 23, 2020 at the Beijing You'an Hospital were summarized and analyzed. Overall, 45 (18 men and 27 women) patients were included in this study. The average age of patients was 58 years (range, 7–94 years). Furthermore, 21 patients (47%) experienced underlying chronic diseases, with another four patients (9%) having three or more chronic diseases simultaneously. The first symptoms appeared at the onset of illness onset include fever in 36 patients (80%), cough in 23 patients (51%), and expectoration in 15 patients (33%), respectively. Patients may experience hepatic and renal injury as well as abnormal myocardial enzymes in varying degrees. Senior patients (≥58) and accompanying chronic diseases were considered as independent predictors for developing a severe and critically ill population with increased mortality. Laboratory results regarding the NEU percentage, NLR, ALC, and C-reactive protein levels were considered significant in predicting clinically critical disease or for prognosis assessment and thus require further studies. COVID-19 may affect multiple organs of the human body. Glucocorticoid is considered effective in the treatment of patients diagnosed with severe COVID-19. Chinese Medical Association Publishing House. Published by Elsevier B.V. 2020-06 2020-05-12 /pmc/articles/PMC7217107/ /pubmed/32835210 http://dx.doi.org/10.1016/j.bsheal.2020.05.003 Text en © 2020 Chinese Medical Association Publishing House. Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Jin, Aihua
Yan, Benyong
Hua, Wei
Feng, Dandan
Xu, Bin
Liang, Lianchun
Guo, Caiping
Clinical characteristics of patients diagnosed with COVID-19 in Beijing
title Clinical characteristics of patients diagnosed with COVID-19 in Beijing
title_full Clinical characteristics of patients diagnosed with COVID-19 in Beijing
title_fullStr Clinical characteristics of patients diagnosed with COVID-19 in Beijing
title_full_unstemmed Clinical characteristics of patients diagnosed with COVID-19 in Beijing
title_short Clinical characteristics of patients diagnosed with COVID-19 in Beijing
title_sort clinical characteristics of patients diagnosed with covid-19 in beijing
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217107/
https://www.ncbi.nlm.nih.gov/pubmed/32835210
http://dx.doi.org/10.1016/j.bsheal.2020.05.003
work_keys_str_mv AT jinaihua clinicalcharacteristicsofpatientsdiagnosedwithcovid19inbeijing
AT yanbenyong clinicalcharacteristicsofpatientsdiagnosedwithcovid19inbeijing
AT huawei clinicalcharacteristicsofpatientsdiagnosedwithcovid19inbeijing
AT fengdandan clinicalcharacteristicsofpatientsdiagnosedwithcovid19inbeijing
AT xubin clinicalcharacteristicsofpatientsdiagnosedwithcovid19inbeijing
AT lianglianchun clinicalcharacteristicsofpatientsdiagnosedwithcovid19inbeijing
AT guocaiping clinicalcharacteristicsofpatientsdiagnosedwithcovid19inbeijing